GO process networks revealed that blood coagulation, involving plasminogen, plasmin, and coagulation factor V, was the second-most significant pathway activated in RA patients, which is consistent with previous findings that blood clotting-related proteins are associated with RA [35–37]. Here, F5 is linked to rheumatoid arthritis.